Introduction {#sec1}
============

It has been reported that Human metapneumovirus (hMPV) was associated with various upper and lower respiratory tract syndromes, including common colds, bronchitis, pneumonia, and asthma exacerbation, with more severe diseases reported for young children, elderly subjects, and immunocompromised patients [@bib1; @bib2; @bib3].

In adults, large outbreaks of hMPV infection in long-term care facilities (LTCF) have been reported, the magnitude and severity of which were similar to those of outbreaks typically associated with influenza or RS virus infection [@bib4; @bib5]. Boivin et al. reported that 9 (9.4%) of 96 patients in the LTCF died due to respiratory infection, including 3 patients who had confirmed hMPV infection [@bib4].

In this report, we found a severe respiratory failure case due to co-infection hMPV and *Streptococcus pneumoniae* in adult patient, and this case was diagnosed by not only routine microbiological methods and but also genetic analysis, including next-generation sequencer.

Case report {#sec2}
===========

A 64-year-old male patient who had been followed up for mild dilated cardiomyopathy became dyspneic and was admitted to our hospital in March 2013. He had been febrile (37.5 °C) for 1 week and had been coughing and short of breath for 2 days although he was a nonsmoker.

His physiological parameters upon admission were as follows: blood pressure 94/52 mmHg, respiratory rate 24 breaths/min and PaO~2~ 62 mmHg, despite the immediate administration of supplemental oxygen (10 L/min).

Laboratory studies revealed no leukocytosis (white blood cells, 3500/mL), but its differentiation was as follows: Neu 87.5%, Lym 7.6%, Mono 3.8%, Eo: 0.6%, and Baso 0.4%, respectively, and inflammation was indicated by C-reactive protein 26.79 mg/dL (\<0.8 mg/dL). In addition, aspartate transaminase 291 U/L and alanine transaminase 381 U/L; mild renal dysfunction was indicated by creatinine 1.18 mg/dL and blood urea nitrogen59 mg/dL. A normal brain natriuretic peptide (BNP) level of 315.4 mg/mL and barely detectable troponin I (0.09 ng/mL) suggested that heart failure had not worsened and that the patient did not have myocardial infarction.

We isolated *S. pneumoniae*, which usually causes lobular pneumonia and/or bronchopneumonia, from the patient\'s sputum samples. Gram staining of the sputum also showed typical lancet-shaped Gram-positive diplococcic. We did not isolated *S. pneumoniae* from the blood samples, but the rapid antigen test of urine for *S. pneumoniae* (Binax Now, Binax, Portland, USA) was also positive. The serotype of the isolated *S. pneumoniae* was 23F deteremined by Quellung reaction, and the MICs in parentheses indicated that the organism was susceptible to ampicillin (2 μg/mL), ceftriaxon (1 μg/mL), levofloxacin (0.5 μg/mL) and meropenem (0.5 μg/mL) determined by using an automated identification system (MicroScan WalkAway; Siemens, Munich, Germany).

However, in addition to no leukocytosis, chest radiography and computed tomography did not reveal a massive infiltration shadow, but rather showed only very mild bronchiolitis, although the patient required ventilator control after admission ([Fig. 1](#fig1){ref-type="fig"}). Therefore, we again considered panbronchiolitis due to atypical pathogens, including mycoplasma, viruses and *Chlamydia*. However, antibodies against *Mycoplasma pneumoniae*, *Chlamydophila pneumoniae* and *Chlamydophila psittaci* were negative, and paired sera did not change. Immunochromatography with Esplain Influenza A&B (Fujirebio Diagnostics Inc., Tokyo, Japan) and Quicknavi-RSV (Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan) confirmed that he was negative for the influenza virus and RSV antigen, respectively.

Shotgun sequencing of nucleic acids extracted from sputum samples using the MiSeq next-generation DNA sequencer (Illumina, San Diego, CA, USA) as described [@bib6], which was performed routinely for difficult to diagnosis cases in our department, detected a 151-base sequence with 99% similarity to a moiety of the human metapneumovirus (hMPV) genome ([Fig. 2](#fig2){ref-type="fig"}). Furthermore, hMPV genes were detected in sputum by regular nested-PCR, and the sequence of this amplicon was reconfirmed as that of hMPV after the extraction of the PCR product. We also confirmed the findings by real-time PCR (Taqman, Light cycler 480, Roche, Basel, Switzerland), which detected 1.9 × 10^4^ copies/mL of the hMPV gene. Diluted antibody for hMPV in his serum was significantly increased to ×10,240, but the rapid antigen detection test (Check hMPV: Meiji Seika Pharma, Tokyo, Japan) was negative.

We diagnosed severe respiratory failure due to panbronchiolitis caused by hMPV and *S. pneumoniae* co-infection. Administration of minocycline (2 × 100 mg/day) and meropenem (3 × 1 g/day) were started because we suspected not only *S. pneumonaie* infection, but also other pathogens including mycoplasma initially. Minocycline was suspended at Day 3, but meropenem was continued for 10 days. These antibacterial therapy and careful respiratory management led to complete recovery.

Discussion {#sec3}
==========

Interactions between viral and bacterial disease are usually interpreted as viral infections predisposing individuals to severe bacterial infections [@bib7; @bib8]. Various mechanisms have been proposed, including virus-induced damage to respiratory cells causing a predisposition to opportunistic bacterial infection or the up-regulation of bacterial adhesion molecules by viral infection [@bib9].

The present study found that exposure to hMPV might modulate *S. pneumoniae* infection. Verkaik et al. screened 57 children aged up to 2 years for colonization with four common respiratory bacterial species associated with seroconversion to hMPV [@bib10]. Whereas a relationship was between exposure to *Haemophilus influenzae*, *Moraxella catarrhalis* or *Staphylococcus aureus* and hMPV seroconversion was not identified, *S. pneumoniae* exposure was significantly associated with increased seroconversion to hMPV. This increase might have been due to increased susceptibility to hMPV infection, increased viral replication or virus spread or enhanced immune responses [@bib10]. The authors concluded from the serological data that either hMPV infection leads to more frequent *S. pneumoniae* carriage or exposure to *S. pneumoniae* increases susceptibility to hMPV infection.

Kukavica-Ibrulj et al. also found that hMPV infection predisposes mice to severe pneumococcal pneumonia [@bib2]. They used an established experimental murine model to validate the hypothesis that hMPV, like influenza virus, increases pneumococcus replication in the lungs and enhances host immunological responses [@bib8]. Secondary bacterial infections often complicate respiratory viral infections, although the mechanisms through which viruses predispose hosts to exacerbated bacterial disease are not completely understood. The most frequently postulated mechanisms include viral destruction of the respiratory epithelium that might increase bacterial adhesion, virus-induced immunosuppression that can lead to bacterial superinfection and an inflammatory response to viral infection that might up-regulate the expression of molecules that bacteria utilize as receptors [@bib2; @bib11].

We found only mild bronchiolitis on chest X-ray and CT images in our patient, although he had symptoms of severe respiratory failure. *S. pneumoniae* usually induces lobular pneumonia or bronchopneumonia when it became a major pathogen. Therefore, hMPV in our patient dominantly infected and induced severe damage to bronchiolar regions, and this process was accelerated by *S. pneumoniae* infection. Colonizing *S. pneumoniae* might increase hMPV infection and replication, and the number of *S. pneumoniae* also synergistically increased. A significant increase in hMPV antibody during the acute phase also suggested previous hMPV infection followed by *S. pneumoniae* infection in our patient. The mechanisms of severe respiratory failure due to hMPV infection followed by *S. pneumoniae* should be further studied.

We detected hMPV sequences from the patient\'s sputum and confirmed the findings by real-time PCR, which detected 1.9 × 10^4^ copies/mL of the hMPV gene. These results suggested that such genetic analysis is valuable when patients present with infection caused by hMPV. We did not detect hMPV antigen by immunochromatography using Check hMPV, which usually detects 1 × 10^6^ copies/mL of the hMPV gene [@bib12; @bib13]. The discrepancy between the positive genetic findings and the negative antigen assays also indicates the value of genetic analysis. Although high-throughput next-generation sequencing technologies might be difficult to apply to routine clinical diagnosis, they have potential for clinical genomic studies, as they can exceed the data output of the most sophisticated capillary sequencers based on the Sanger method [@bib14]. We suggest that genetic analysis of samples along with cultures should become routine practice [@bib15].

In conclusion, we described severe respiratory failure caused by co-infection with hMPV and *S. pneumoniae* in a patient whose chest X-ray and CT images showed only mild bronchitis. Genetic analysis, such as next-generation sequencing, revealed hMPV infection. Synergistic effects between hMPV and bacteria should be fully investigated.

![Chest radiography (A) and computed tomography (B) images upon admission. Absence of consolidation and small multiple lobular shadows in upper and middle fields of right lung suggests bronchiolitis.](gr1){#fig1}

![Genetic analysis of hMPV in sputum. Alignment of complete HMPV genome sequence by nucleotide sequence using BLASTN. Reading obtained with MiSeq sequencer (query) was compared with that of HMPV strain Sabana (Subject: NCBI accession number, [HM197719.1](ncbi-n:HM197719.1){#intref0010}).](gr2){#fig2}
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